Format

Send to

Choose Destination
Neuro Oncol. 2018 Jan 10;20(1):144-145. doi: 10.1093/neuonc/nox219.

Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee".

Author information

1
Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
2
Department of Radiology, Children's National Medical Center, Rockville, Maryland, USA.
3
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts, USA.
4
Department of Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
5
Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, Rockville, Maryland, USA.
6
Pediatric Neuro-Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
PMID:
29329453
PMCID:
PMC5761509
DOI:
10.1093/neuonc/nox219
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center